$0.58 EPS Expected for Commscope Holding Company Inc (NASDAQ:COMM) This Quarter

Share on StockTwits

Wall Street brokerages predict that Commscope Holding Company Inc (NASDAQ:COMM) will announce $0.58 earnings per share for the current fiscal quarter, according to Zacks. Five analysts have provided estimates for Commscope’s earnings, with estimates ranging from $0.55 to $0.62. Commscope reported earnings of $0.68 per share in the same quarter last year, which indicates a negative year over year growth rate of 14.7%. The company is scheduled to report its next quarterly earnings report on Tuesday, July 30th.

According to Zacks, analysts expect that Commscope will report full year earnings of $2.55 per share for the current year, with EPS estimates ranging from $2.47 to $2.65. For the next year, analysts expect that the company will report earnings of $3.18 per share, with EPS estimates ranging from $2.75 to $3.62. Zacks Investment Research’s EPS calculations are an average based on a survey of research analysts that cover Commscope.

Commscope (NASDAQ:COMM) last announced its quarterly earnings results on Thursday, May 9th. The communications equipment provider reported $0.48 EPS for the quarter, beating analysts’ consensus estimates of $0.41 by $0.07. Commscope had a return on equity of 23.46% and a net margin of 2.29%. The company had revenue of $1.10 billion during the quarter, compared to analyst estimates of $1.08 billion. During the same period in the prior year, the company earned $0.49 earnings per share. The firm’s revenue was down 1.9% on a year-over-year basis.

A number of equities research analysts have issued reports on the company. Zacks Investment Research upgraded Investar from a “hold” rating to a “buy” rating and set a $27.00 price objective on the stock in a research report on Tuesday, June 4th. Morgan Stanley restated a “top pick” rating on shares of in a research report on Wednesday, June 5th. Rosenblatt Securities upgraded Juniper Networks from a “sell” rating to a “neutral” rating and upped their price objective for the company from $24.00 to $27.00 in a research report on Wednesday, June 12th. BidaskClub upgraded ZIOPHARM Oncology from a “buy” rating to a “strong-buy” rating in a research report on Monday, June 17th. Finally, ValuEngine upgraded Yandex from a “hold” rating to a “buy” rating in a research report on Saturday, April 13th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and ten have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $24.47.

In other news, Director Frank M. Drendel sold 80,800 shares of the stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $15.84, for a total value of $1,279,872.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, COO Bruce William Mcclelland purchased 3,500 shares of Commscope stock in a transaction dated Wednesday, May 22nd. The stock was acquired at an average price of $18.00 per share, for a total transaction of $63,000.00. The disclosure for this purchase can be found here. Corporate insiders own 3.25% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the company. Machina Capital S.A.S. raised its holdings in shares of Commscope by 174.1% in the second quarter. Machina Capital S.A.S. now owns 5,236 shares of the communications equipment provider’s stock worth $82,000 after buying an additional 3,326 shares during the period. Advisors Asset Management Inc. raised its holdings in shares of Commscope by 200.6% in the first quarter. Advisors Asset Management Inc. now owns 6,382 shares of the communications equipment provider’s stock worth $139,000 after buying an additional 4,259 shares during the period. Wiley BROS. Aintree Capital LLC purchased a new stake in shares of Commscope in the second quarter worth approximately $164,000. Bank of Montreal Can raised its holdings in shares of Commscope by 24.9% in the first quarter. Bank of Montreal Can now owns 8,256 shares of the communications equipment provider’s stock worth $179,000 after buying an additional 1,644 shares during the period. Finally, New Jersey Better Educational Savings Trust purchased a new stake in shares of Commscope in the second quarter worth approximately $189,000. Hedge funds and other institutional investors own 97.74% of the company’s stock.

Commscope stock traded up $0.05 during midday trading on Friday, reaching $14.64. 3,289,298 shares of the stock traded hands, compared to its average volume of 2,730,002. The business’s fifty day moving average price is $15.85. Commscope has a 12 month low of $14.29 and a 12 month high of $32.48. The company has a market cap of $2.82 billion, a PE ratio of 6.94, a P/E/G ratio of 0.33 and a beta of 1.41. The company has a current ratio of 2.01, a quick ratio of 1.42 and a debt-to-equity ratio of 4.28.

Commscope Company Profile

CommScope Holding Company, Inc provides infrastructure solutions for communications networks worldwide. The company's CommScope Connectivity Solutions segment offers optical fiber and twisted pair structured cable solutions, intelligent infrastructure software, and network rack and cabinet enclosures under the SYSTIMAX, NETCONNECT, and Uniprise brands; and fiber management systems, patch cords and panels, pre-terminated fiber connectivity, complete cabling systems, and cable assemblies for use in offices and data centers.

Featured Story: Trading signals using Bollinger bands

Get a free copy of the Zacks research report on Commscope (COMM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Commscope (NASDAQ:COMM)

Receive News & Ratings for Commscope Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Commscope and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.